Tuesday, January 09, 2024 10:23:48 AM
dont ask me questions that you can research easily yourself.
https://find-and-update.company-information.service.gov.uk/company/08717711/persons-with-significant-control
ADVENT BIOSERVICES LTD
2 active persons with significant control / 0 active statements
Toucan Holdings Llc ACTIVE
Correspondence address
7513 7513 Connelley Drive, Suite I, Hanover, Maryland, United States, 21076
Notified on
30 December 2019
Governing law
Usa
Legal form
Limited Liability Company
Nature of control
Ownership of shares – 75% or more
Ms Linda Fairing Powers ACTIVE
Correspondence address
Sawston Business Park, Sawston, Cambridge, United Kingdom, CB22 3JG
Notified on
6 April 2016
Date of birth
October 1955
Nationality
American
Country of residence
United States
https://find-and-update.company-information.service.gov.uk/company/08717711/persons-with-significant-control
ADVENT BIOSERVICES LTD
2 active persons with significant control / 0 active statements
Toucan Holdings Llc ACTIVE
Correspondence address
7513 7513 Connelley Drive, Suite I, Hanover, Maryland, United States, 21076
Notified on
30 December 2019
Governing law
Usa
Legal form
Limited Liability Company
Nature of control
Ownership of shares – 75% or more
Ms Linda Fairing Powers ACTIVE
Correspondence address
Sawston Business Park, Sawston, Cambridge, United Kingdom, CB22 3JG
Notified on
6 April 2016
Date of birth
October 1955
Nationality
American
Country of residence
United States
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
